Embryonic lethal genetic variants and chromosomally normal pregnancy loss

Fertil Steril. 2021 Nov;116(5):1351-1358. doi: 10.1016/j.fertnstert.2021.06.039.

Abstract

Objective: To examine whether rare damaging genetic variants are associated with chromosomally normal pregnancy loss and estimate the magnitude of the association.

Design: Case-control.

Setting: Cases were derived from a consecutive series of karyotyped losses at one New Jersey hospital. Controls were derived from the National Database for Autism Research.

Patient(s): Cases comprised 19 chromosomally normal loss conceptus-parent trios. Controls comprised 547 unaffected siblings of autism case-parent trios.

Intervention(s): None.

Main outcome measure(s): The rate of damaging variants in the exome (loss of function and missense-damaging) and the proportions of probands with at least one such variant among cases vs. controls.

Results: The proportions of probands with at least one rare damaging variant were 36.8% among cases and 22.9% among controls (odds ratio, 2.0; 99% confidence interval, 0.5-7.3). No case had a variant in a known fetal anomaly gene. The proportion with variants in possibly embryonic lethal genes increased in case probands (odds ratio, 14.5; 99% confidence interval, 1.5-89.7); variants occurred in BAZ1A, FBN2, and TIMP2.

Conclusion(s): Rare genetic variants in the conceptus may be a cause of chromosomally normal pregnancy loss. A larger sample is needed to estimate the magnitude of the association with precision and identify relevant biologic pathways.

Keywords: Chromosomally normal; embryonic lethal; epidemiology; genetic variants; pregnancy loss.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Abortion, Spontaneous / diagnosis
  • Abortion, Spontaneous / genetics*
  • Case-Control Studies
  • Chromosomal Proteins, Non-Histone / genetics
  • Chromosomes, Human*
  • DNA Mutational Analysis
  • Exome Sequencing
  • Female
  • Fibrillin-2 / genetics
  • Humans
  • Karyotype
  • Karyotyping
  • Loss of Function Mutation*
  • Mutation, Missense*
  • Pregnancy
  • Risk Assessment
  • Risk Factors
  • Tissue Inhibitor of Metalloproteinase-2 / genetics

Substances

  • BAZ1A protein, human
  • Chromosomal Proteins, Non-Histone
  • FBN2 protein, human
  • Fibrillin-2
  • TIMP2 protein, human
  • Tissue Inhibitor of Metalloproteinase-2